SpectraCure
Developing a high-precision, minimally invasive therapy for internal tumors like prostate cancer.
SPEC | ST
Overview
Corporate Details
- ISIN(s):
- SE0007158118
- LEI:
- 549300U3BMSZ5VGYC283
- Country:
- Sweden
- Address:
- GASVERKSGATAN, 1, 222 29 Lund
- Website:
- https://spectracure.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
SpectraCure is a medical technology company focused on the development and commercialization of a proprietary, patented treatment system for internal solid tumors. The company's primary clinical focus is on localized prostate cancer, offering a minimally invasive, high-precision focal therapy for both primary and recurrent cases. The system is designed to provide an individualized treatment solution to eliminate deep-seated tumors while preserving healthy tissue. Clinical trials are underway at leading clinics in North America and Europe. The platform technology has potential future applications for other solid cancers, such as those in the breast, pancreas, and head and neck region.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SpectraCure filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SpectraCure via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
